NPI: 1629186374 · CAMDEN, NJ 08103 · Non-Surgical Family Planning Clinic/Center · NPI assigned 08/25/2006
Authorized official STILES, SANDY controls 13+ related entities in our dataset. Read more
| Authorized Official | STILES, SANDY (SPECIAL PROJECTS LIASION) |
| NPI Enumeration Date | 08/25/2006 |
Other providers sharing the same authorized official: STILES, SANDY
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 11,944 | $946K |
| 2019 | 9,728 | $620K |
| 2020 | 8,427 | $481K |
| 2021 | 9,271 | $467K |
| 2022 | 8,575 | $424K |
| 2023 | 7,758 | $451K |
| 2024 | 4,751 | $363K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 11,036 | 10,466 | $1.01M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5,848 | 5,848 | $836K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 5,755 | 5,749 | $562K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 1,832 | 1,826 | $229K |
| 99201 | 1,565 | 1,565 | $228K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,059 | 2,941 | $192K |
| 81025 | 13,885 | 13,664 | $138K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 119 | 119 | $98K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2,531 | 2,414 | $98K |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 4,328 | 4,271 | $91K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 459 | 459 | $48K |
| 87806 | 1,027 | 1,027 | $44K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 5,014 | 4,983 | $31K |
| 58300 | 230 | 225 | $28K | |
| J7298 | Levonorgestrel-releasing intrauterine contraceptive system (mirena), 52 mg | 28 | 28 | $25K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 263 | 263 | $25K |
| 86703 | 1,236 | 1,236 | $22K | |
| J8499 | Prescription drug, oral, non chemotherapeutic, nos | 903 | 887 | $14K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 151 | 146 | $12K |
| 11981 | 68 | 68 | $8K | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 13 | 13 | $3K |
| J7304 | Contraceptive supply, hormone containing patch, each | 28 | 28 | $2K |
| 58301 | 14 | 14 | $2K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 39 | 38 | $2K |
| 11982 | 15 | 15 | $2K | |
| 76857 | 37 | 35 | $1K | |
| 86901 | 673 | 671 | $1K | |
| 87210 | 139 | 139 | $333.60 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 40 | 40 | $40.00 |
| 85018 | 25 | 25 | $30.00 | |
| 86780 | 94 | 92 | $0.00 |